Skip to main content
Jasper Therapeutics, Inc. logo

Jasper Therapeutics, Inc. — Investor Relations & Filings

Ticker · JSPR ISIN · US4718712023 US Professional, scientific and technical activities
Open in API
Filings indexed 422 across all filing types
Latest filing 2022-03-23 Director's Dealing
Country US United States of America
Listing US JSPR

About Jasper Therapeutics, Inc.

https://jaspertx.com/

Jasper Therapeutics, Inc. is a clinical-stage biotechnology company that develops therapies targeting mast and hematopoietic stem cells. The company's lead product candidate is briquilimab, a monoclonal antibody that targets c-Kit (CD117). This therapeutic is designed to deplete mast cells for the treatment of chronic immunological and inflammatory diseases. Jasper Therapeutics is conducting clinical studies to evaluate briquilimab in patients with chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU), and allergic asthma. The company's mission is to provide safer and more effective therapies for patients with chronic mast cell-driven diseases.

Recent filings

Filing Released Lang Actions
Director's Dealing 2022
Director's Dealing
2022-03-23 English
Director's Dealing 2022
Director's Dealing
2022-03-23 English
Director's Dealing 2022
Director's Dealing
2022-03-23 English
Director's Dealing 2022
Director's Dealing
2022-03-23 English
Director's Dealing 2022
Director's Dealing
2022-03-23 English
REGISTRATION STATEMENT
Regulatory Filings Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as equity incentive plans. It includes detailed information about stock options and restricted stock units issuable under various equity incentive plans, and a reoffer prospectus for shares held by selling stockholders who are directors and executive officers. The document is not an annual or quarterly financial report, earnings release, or management discussion. It is a regulatory filing related to securities registration and offering, specifically a registration statement for employee stock plans. This type of document does not fit into categories like Annual Report, Earnings Release, or Capital/Financing Update, but rather falls under Regulatory Filings (RNS) as a general SEC filing that does not fit other specific categories.
2022-03-22 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.